These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 895595)

  • 1. Evaluation of novel sorbent systems for joint hemodialysis and hemoperfusion.
    Denti E; Walker JM; Brancaccio D; Tessore V
    Med Instrum; 1977; 11(4):212-6. PubMed ID: 895595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clincial performance characteristics of a new combined system for simulatenous hemoperfusion-hemodialysis-ultrafiltration in series.
    Chang TM; Chirito E; Barre B; Cole C; Hewish M
    Trans Am Soc Artif Intern Organs; 1975; 21():502-9. PubMed ID: 1146025
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated carbon fibers in hemoperfusion devices.
    Davis TA
    Kidney Int Suppl; 1975 Feb; (3):406-8. PubMed ID: 1099319
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal.
    Chang TM; Gonda A; Dirks JH; Malave N
    Trans Am Soc Artif Intern Organs; 1971; 17():246-52. PubMed ID: 5158100
    [No Abstract]   [Full Text] [Related]  

  • 5. Sorbent membranes used in a conventional dialyzer format. In vitro and clinical evaluation.
    Gurland HJ; Fernandez JC; Samtleben W; Castro LA
    Artif Organs; 1978 Nov; 2(4):372-4. PubMed ID: 743008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and engineering evaluation of disposable envelope inserts for the Kiil dialyzer.
    Nosé Y; Mrava GL; Weber DC; Kon T; Nakamoto S; Popowniak KL; Kuruvila C
    Trans Am Soc Artif Intern Organs; 1969; 15():118-26. PubMed ID: 5791375
    [No Abstract]   [Full Text] [Related]  

  • 7. [Repeated hemodialysis with the Kiil artificial kidney with 3 dialyzing compartments. Clinical experience and evaluation "in vitro" of its effectiveness].
    Biagini M; Menichini G
    Minerva Nefrol; 1968; 15(5):342-5. PubMed ID: 5743463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemoperfusion with coated activated charcoal for treating acute poisoning by remedies, plant protectants, and fungi. I. Remedies (author's transl)].
    Okonek S
    Med Klin; 1976 Jun; 71(26):1120-4. PubMed ID: 934007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary technical and clinical evaluation of a new hollow fiber dialyzer with a 5 microns thick cuprophan membrane.
    Ronco C; Brendolan A; Bragantini L; Chiaramonte S; Fabris A; Feriani M; Dell'Aquila R; Milan M; La Greca G
    Clin Nephrol; 1986; 26 Suppl 1():S17-21. PubMed ID: 3829463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible new sorbent dialyser for haemodialysis.
    Ioakim P; Rosen D
    Biomed Eng; 1976 Oct; 11(10):351-3. PubMed ID: 974213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and future perspectives of extracorporeal blood purification].
    Falkenhagen D; Ahrenholz P; Klinkmann H
    Z Gesamte Inn Med; 1986 May; 41(10):297-305. PubMed ID: 3751193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous hemodialysis with cuprophan membranes in critical patients].
    Cotera A; Lorca E; Saffie A; Sepulveda M
    Rev Med Chil; 1994 Apr; 122(4):394-400. PubMed ID: 7809533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane permeability for inorganic phosphate ion.
    Moise O; Sideman S; Hoffer E; Rousseau I; Better OS
    J Biomed Mater Res; 1977 Nov; 11(6):903-13. PubMed ID: 591528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of hemodialysis and hemoperfusion in a single unit for treatment of uremia.
    Gurland HJ; Castro LA; Samtleben W; Fernandez JC
    Clin Nephrol; 1979 Mar; 11(3):167-72. PubMed ID: 436347
    [No Abstract]   [Full Text] [Related]  

  • 16. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
    Ifediora OC; Teehan BP; Sigler MH
    ASAIO J; 1992; 38(3):M697-701. PubMed ID: 1457952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The consequences of physiological resistances on metabolite removal from the patient-artifical kidney system.
    Popovich RP; Hlavinka DJ; Bomar JB; Moncrief JW; Decherd JF
    Trans Am Soc Artif Intern Organs; 1975; 21():108-16. PubMed ID: 1145983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodialysis and hemosorption in acute kidney failure].
    Kanus II
    Urol Nefrol (Mosk); 1990; (1):13-6. PubMed ID: 2336750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary decontamination: when are hemodialysis and hemoperfusion indicated?].
    Keusch G
    Ther Umsch; 1992 Feb; 49(2):113-7. PubMed ID: 1553624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoperfusion in the treatment of uremia.
    Gurland HJ
    Kidney Int Suppl; 1985 Dec; 17():S47-9. PubMed ID: 3912588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.